CClinicalTrials.gg
CompletedNCT07536217Updated Jun 3, 2026

Developmental Pilot of Support Groups for Caregivers of Children With DLD

An interventional study of Support Groups in Developmental Language Disorder, sponsored by University of Delaware. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by University of Delaware · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to test a new support group curriculum that we designed to support parents of children with Developmental Language Disorder (DLD).

Read the detailed description

After completing the informed consent process and eligibility has been verified, participants will complete parenting questionnaires. They will then be asked to attend 8-10 weekly support group meetings with other participants. Support group meetings are held remotely. After each meeting, participants will be asked to complete a brief questionnaire to learn about their experiences. After the final support group meeting, participants will be asked to complete the same parenting questionnaires as at study initiation. Participants will also be asked to complete a focus group with other support group attendees to share about their experiences in the group.

02

Conditions studied

  • Developmental Language Disorder

Keywords

  • Support Groups
  • Developmental Language Disorder
  • EPIS
  • Implementation Science
  • Peer Support
03

In context

Language Development Disorders

114 studies on the registry are indexed under Language Development Disorders; 47 are open to participants now.

This study's enrollment of 11 is below the median of 71 across 100 interventional studies indexed under Language Development Disorders.

Browse Language Development Disorders studies →

Lead sponsor

University of Delaware is the lead sponsor of 125 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Caregiver of an elementary aged (5-12 year old) child with a lab-confirmed diagnosis of DLD

Exclusion criteria

Exclusion Criteria:

  • Not able to participate via teletherapy in a support group delivered in English.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Developmental Pilot for Support Groups

    Participants will join a teletherapy delivered support group for caregivers of children with DLD. They will attend 8-10 weekly support group meetings and provide feedback on the meeting content and format so that we can revise the materials and evaluate early efficacy prior to a larger in person pilot.

    Behavioral: Support Groups

Interventions

  • BehavioralSupport Groups

    A manualized support group for families who care for a child with developmental language disorder (DLD)

06

What researchers measure

Primary outcomes

  1. Qualitative interviews with participants

    Focus group and/or one-on-one interviews with support group participants

    Time frame: up to 2 weeks after intervention

Secondary outcomes

  1. Survey on Knowledge Seeking Behaviors

    We will use a survey developed by Darefsky (2022, adapted from (Al-Daihani \& Al-Ateeqi, 2015). The survey consists of 9 total questions, of which there are two yes/no items, two multiple choice items, and four Likert scale items. This measure is not scored in a way that results in minimum or maximum scores, or outcomes. This measure is used to collect descriptive information about types and sources of information that caregivers desire in relation to their child's diagnosis.

    Time frame: up to 4 weeks before and 2 weeks after intervention

  2. Child Adjustment and Parent Efficacy Scale

    The Child Adjustment and Parent Efficacy Scale (CAPES; Morawska \& Sanders, 2010) includes 50 Likert scale items This yields two measurements: one for Child Emotional and Behavioral Problems and one for Parent Efficacy. Child Emotional and Behavioral Problems: Minimum score = 0; Maximum score = 81. Higher scores indicate greater levels of child problems. Parent Efficacy: Minimum score = 19; Maximum score = 190 Higher scores indicate greater levels of parent self-efficacy.

    Time frame: up to 4 weeks before and 2 weeks after intervention

  3. Parenting Stress Index, Fourth Edition Short Form

    The Parenting Stress Index, Fourth Edition Short Form (PSI-4-SF; Abidin, 2012)includes 36 items. Minimum score = 36; Maximum score = 180. Higher scores indicate higher parent stress levels.

    Time frame: up to 4 weeks before and 2 weeks after intervention

  4. Family Support Scale

    The Family Support Scale (FSS; Dunst, et al., 1984)includes 18 Likert scale items. Minimum score = 0 Maximum score = 95 Higher scores indicate more family support.

    Time frame: up to 4 weeks before and 2 weeks after intervention

Other outcomes

  1. Weekly Support Group Attendance

    We track individual attendance at each support group meeting. Minimum score is 1 and maximum score is 8. The maximum score indicates full participation in all meetings.

    Time frame: throughout intervention, up to 8 weeks.

07

Study locations

1 site
  • University of Delaware
    Newark, Delaware 19713, United States
08

References and documents

Individual participant data

Plan to share: Yes — The ICPSR (Inter-university Consortium for Political and Social Research) data repositories and data management standards apply here. In all cases, we offer participants the chance to opt out of data sharing. The following applies to those who agree to data sharing. For focus groups and participant interviews which cannot be fully de-identified, we will share redacted transcripts with individuals with an IRB with access managed by ICPSR. For pre/post measures and daily surveys of participation, we will share de-identified data sets.

Supporting information: Study protocol, Sap, Icf, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07536217
Lead sponsor
University of Delaware
Responsible party
Sponsor
First posted
Apr 17, 2026
Start date
Feb 20, 2026
Primary completion
May 28, 2026
Completion
May 28, 2026
Last update
Jun 3, 2026

Study contacts

Amanda Van Horne, PhD
principal investigator · University of Delaware

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion